An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study.
OBJECTIVE
Women with a fetal death at the time of diagnosis have higher maternal plasma concentrations of the anti-angiogenic factor, soluble vascular endothelial growth factor receptor (sVEGFR)-1, than women with a normal pregnancy. An important question is whether these changes are the cause or consequence of fetal death. To address this issue, we conducted a longitudinal study and measured the maternal plasma concentrations of selective angiogenic and anti-angiogenic factors before the diagnosis of a fetal death. The anti-angiogenic factors studied were sVEGFR-1 and soluble endoglin (sEng), and the angiogenic factor, placental growth factor (PlGF).


METHODS
This retrospective longitudinal nested case-control study included 143 singleton pregnancies in the following groups: (1) patients with uncomplicated pregnancies who delivered a term infant with an appropriate weight for gestational age (n=124); and (2) patients who had a fetal death (n=19). Blood samples were collected at each prenatal visit, scheduled at 4-week intervals from the first trimester until delivery. Plasma concentrations of sVEGFR-1, sEng, and PlGF were determined by specific and sensitive ELISA. A linear mixed-effects model was used for analysis.


RESULTS
(1) The average profiles of analyte concentrations as a function of gestational age for sVEGFR-1, sEng and PlGF were different between women destined to have a fetal death and those with a normal pregnancy after adjusting for covariates (p<0.05); (2) Plasma sVEGFR-1 concentrations in patients destined to have a fetal death were significantly lower between 7 and 11 weeks of gestation and became significantly higher than those of women with a normal pregnancy between 20 and 37 weeks of gestation (p<0.05); (3) Similarly, plasma sEng concentrations of women destined to have a fetal death were lower at 7 weeks of gestation (p=0.04) and became higher than those of controls between 20 and 40 weeks of gestation (p<0.05); (4) In contrast, plasma PlGF concentrations were higher among patients destined to develop a fetal death between 7 and 14 weeks of gestation and became significantly lower than those in the control group between 22 and 39 weeks of gestation (p<0.05); (5) The ratio of PlGF/(sVEGFR-1 × sEng) was significantly higher in women destined to have a fetal death between 7 and 13 weeks of gestation (94-781%) and significantly lower (44-75%) than those in normal pregnant women between 20 and 40 weeks of gestation (p<0.05); (6) Similar results were obtained when patients with a fetal death were stratified into those who were diagnosed before or after 37 weeks of gestation.


CONCLUSIONS
Fetal death is characterised by higher maternal plasma concentrations of PlGF during the first trimester compared to normal pregnancy. This profile changes into an anti-angiogenic one during the second and third trimesters.
Romero
Roberto
R
Perinatology Research Branch, NICHD, NIH, DHHS, Wayne State University/Hutzel Women's Hospital, 3990 John R, Box 4, Detroit, MI 48201, USA. prbchiefstaff@med.wayne.edu
Chaiworapongsa
Tinnakorn
T
Erez
Offer
O
Tarca
Adi L
AL
Gervasi
Maria Teresa
MT
Kusanovic
Juan Pedro
JP
Mittal
Pooja
P
Ogge
Giovanna
G
Vaisbuch
Edi
E
Mazaki-Tovi
Shali
S
Dong
Zhong
Z
Kim
Sun Kwon
SK
Yeo
Lami
L
Hassan
Sonia S
SS
D000293:Adolescent; D000328:Adult; D015703:Antigens, CD / Q000097:blood*; D000071063:Endoglin; D005260:Female; D005313:Fetal Death / Q000097:blood*; D005865:Gestational Age; D006801:Humans; D008137:Longitudinal Studies; D008875:Middle Aged; D018919:Neovascularization, Physiologic; D000072483:Placenta Growth Factor; D011247:Pregnancy; D011257:Pregnancy Proteins / Q000097:blood*; D011956:Receptors, Cell Surface / Q000097:blood*; D012189:Retrospective Studies; D040281:Vascular Endothelial Growth Factor Receptor-1 / Q000097:blood*
D015703:Antigens, CD; C064206:ENG protein, human; D000071063:Endoglin; C000608036:PGF protein, human; D011257:Pregnancy Proteins; D011956:Receptors, Cell Surface; D000072483:Placenta Growth Factor; D040281:Vascular Endothelial Growth Factor Receptor-1
Am J Obstet Gynecol. 2008 Sep;199(3):319.e1-4
18771999
Aust N Z J Obstet Gynaecol. 2009 Oct;49(5):467-71
19780727
Am J Obstet Gynecol. 1999 Sep;181(3):718-24
10486489
Aust N Z J Public Health. 2007 Oct;31(5):444-9
17931292
N Engl J Med. 2006 Sep 7;355(10):992-1005
16957146
J Soc Gynecol Investig. 2004 Sep;11(6):342-52
15350246
Hum Reprod Update. 2006 Nov-Dec;12(6):747-55
16682385
Semin Fetal Neonatal Med. 2009 Aug;14(4):182-9
19285457
Paediatr Perinat Epidemiol. 1995 Oct;9(4):431-40
8570468
Br J Obstet Gynaecol. 1999 Oct;106(10):1019-22
10519425
Acta Obstet Gynecol Scand. 2004 Sep;83(9):801-7
15315590
J Matern Fetal Neonatal Med. 2005 Jul;18(1):9-16
16105786
N Engl J Med. 2004 Feb 12;350(7):672-83
14764923
Br J Obstet Gynaecol. 1992 Feb;99(2):159-60
1554671
Ultrasound Obstet Gynecol. 1996 Feb;7(2):114-21
8776236
Am J Obstet Gynecol. 2005 Dec;193(6):1923-35
16325593
Obstet Gynecol. 1992 Aug;80(2):283-5
1635745
Placenta. 2008 Jan;29(1):71-80
17963842
Placenta. 2000 Mar-Apr;21 Suppl A:S16-24
10831117
Am J Obstet Gynecol. 2008 Sep;199(3):268.e1-9
18771979
Ultrasound Obstet Gynecol. 1991 Nov 1;1(6):435-45
12797030
Am J Obstet Gynecol. 2003 Sep;189(3):861-73
14526331
Obstet Gynecol. 2002 Dec;100(6):1183-9
12468161
Nat Rev Nephrol. 2009 Nov;5(11):658-62
19855426
J Clin Endocrinol Metab. 2003 May;88(5):2348-51
12727995
Am J Obstet Gynecol. 2007 Apr;196(4):326.e1-13
17403407
Nature. 1996 Apr 4;380(6573):439-42
8602242
J Matern Fetal Neonatal Med. 2006 Oct;19(10):607-13
17118734
Science. 1997 Sep 12;277(5332):1669-72
9287221
Am J Obstet Gynecol. 2004 Jun;190(6):1541-7; discussion 1547-50
15284729
Eur J Obstet Gynecol Reprod Biol. 2005 Sep 1;122(1):33-9
15935542
J Matern Fetal Neonatal Med. 2003 Sep;14(3):151-7
14694969
Placenta. 2005 Feb-Mar;26(2-3):114-23
15708112
Am J Obstet Gynecol. 2007 Aug;197(2):174.e1-5
17689640
Am J Obstet Gynecol. 2007 Mar;196(3):239.e1-6
17346536
Rev Med Chil. 2004 Oct;132(10):1155-65
15631202
Am J Obstet Gynecol. 2004 Oct;191(4):1240-6
15507947
Obstet Gynecol. 2009 Oct;114(4):901-914
19888051
Obstet Gynecol. 2009 Oct;114(4):809-817
19888039
Am J Obstet Gynecol. 1976 Jul 15;125(6):740-6
937399
BJOG. 2006 Apr;113(4):393-401
16553651
J Clin Endocrinol Metab. 1998 May;83(5):1697-705
9589679
Placenta. 2000 Jul-Aug;21(5-6):443-50
10940194
Am J Obstet Gynecol. 1987 Jul;157(1):162-8
3300349
Placenta. 2001 Nov;22(10):795-9
11718565
Obstet Gynecol. 2007 May;109(5):1205-6; author reply 1206
17470610
J Matern Fetal Neonatal Med. 2008 Jan;21(1):9-23
18175241
Hypertension. 2007 Jul;50(1):137-42
17515455
Placenta. 2003 Apr;24 Suppl A:S86-93
12852418
J Clin Endocrinol Metab. 2007 Jul;92(7):2831-4
17426082
Hum Pathol. 2003 Dec;34(12):1265-75
14691912
Obstet Gynecol. 2007 Jun;109(6):1316-24
17540803
J Matern Fetal Neonatal Med. 2009 Dec;22(12):1122-39
19916710
Eur J Obstet Gynecol Reprod Biol. 2003 Sep 22;110 Suppl 1:S10-8
12965086
Am J Pathol. 2000 Dec;157(6):2111-22
11106583
J Matern Fetal Neonatal Med. 2008 Jan;21(1):25-40
18175242
PLoS One. 2008 Jun 04;3(6):e2302
18523681
Clin Sci (Lond). 2007 Jan;112(1):51-7
16928195
Am J Obstet Gynecol. 2001 May;184(6):1267-72
11349200
Am J Obstet Gynecol. 2005 Sep;193(3 Pt 1):894; author reply 894-5
16150301
Am J Pathol. 2003 Jan;162(1):115-25
12507895
Acta Obstet Gynecol Scand. 2008;87(11):1202-12
18951207
Obstet Gynecol. 2007 Jun;109(6):1368-74
17540809
Am J Obstet Gynecol. 2003 Jan;188(1):177-82
12548214
J Clin Endocrinol Metab. 2004 Feb;89(2):770-5
14764795
J Matern Fetal Neonatal Med. 2009 Nov;22(11):1021-38
19900040
BMC Pregnancy Childbirth. 2009 Jun 10;9:22
19515228
Hum Reprod. 1999 Nov;14(11):2901-4
10548645
BMJ. 2005 Nov 12;331(7525):1113-7
16236774
Nature. 1996 Apr 4;380(6573):435-9
8602241
Hypertens Pregnancy. 2005;24(3):313-7
16263603
J Anat. 1960 Jul;94:297-328
14399291
Acta Obstet Gynecol Scand. 2010;89(1):143-6
20021269
Hypertens Res. 2007 Feb;30(2):151-9
17460385
Lab Invest. 1999 Feb;79(2):151-70
10068204
J Clin Endocrinol Metab. 2003 Nov;88(11):5555-63
14602804
Ultrasound Obstet Gynecol. 2007 Apr;29(4):407-13
17330322
J Matern Fetal Neonatal Med. 2005 Jan;17(1):3-18
15804781
Am J Obstet Gynecol. 2007 Aug;197(2):211.e1-4
17689655
Am J Obstet Gynecol. 2005 Sep;193(3 Pt 2):984-9
16157098
Placenta. 2000 Mar-Apr;21 Suppl A:S31-7
10831119
N Engl J Med. 2006 Apr 27;354(17):1857-8
16641410
Obstet Gynecol. 2006 Aug;108(2):338-44
16880304
Placenta. 1997 May;18(4):295-9
9179923
Am J Obstet Gynecol. 2006 Jul;195(1):255-9
16813756
Fertil Steril. 1993 Aug;60(2):293-7
8339826
Am J Obstet Gynecol. 2004 Aug;191(2):477-80
15343224
Am J Obstet Gynecol. 2008 Feb;198(2):175.e1-6
18226617
J Clin Invest. 2003 Mar;111(5):649-58
12618519
Clin Exp Obstet Gynecol. 1980;7(4):210-4
7261352
Am J Obstet Gynecol. 2006 Jul;195(1):201-7
16545329
Am J Obstet Gynecol. 2007 Jul;197(1):28.e1-6
17618745
Am J Obstet Gynecol. 2008 Apr;198(4):382.e1-8
18395032
Am J Obstet Gynecol. 2006 Dec;195(6):1668-73
16643817
Am J Pathol. 2000 Dec;157(6):1759-68
11106547
Am J Obstet Gynecol. 2007 Aug;197(2):176.e1-6
17689641
Obstet Gynecol. 2008 Oct;112(4):765-71
18827118
J Matern Fetal Neonatal Med. 2007 Jul;20(7):495-507
17674262
BMJ. 1998 May 16;316(7143):1483-7
9582131
Obstet Gynecol. 2007 Jan;109(1):153-67
17197601
J Matern Fetal Neonatal Med. 2008 May;21(5):279-87
18446652
Nature. 1995 Jul 6;376(6535):66-70
7596436
Bull World Health Organ. 2006 Sep;84(9):699-705
17128339
J Clin Endocrinol Metab. 2006 Jan;91(1):180-4
16263826
BJOG. 2009 Sep;116(10):1356-63
19538413
Semin Perinatol. 2000 Feb;24(1):82-6
10709867
BMC Pregnancy Childbirth. 2009 Jun 19;9:24
19538759